| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |